316 related articles for article (PubMed ID: 11264182)
21. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
22. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
23. Linking Smads and transcriptional activation.
Inman GJ
Biochem J; 2005 Feb; 386(Pt 1):e1-e3. PubMed ID: 15702493
[TBL] [Abstract][Full Text] [Related]
24. Determinants of specificity in TGF-beta signal transduction.
Chen YG; Hata A; Lo RS; Wotton D; Shi Y; Pavletich N; Massagué J
Genes Dev; 1998 Jul; 12(14):2144-52. PubMed ID: 9679059
[TBL] [Abstract][Full Text] [Related]
25. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
26. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
[TBL] [Abstract][Full Text] [Related]
27. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.
Bex F; Yin MJ; Burny A; Gaynor RB
Mol Cell Biol; 1998 Apr; 18(4):2392-405. PubMed ID: 9528808
[TBL] [Abstract][Full Text] [Related]
28. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control.
Van Orden K; Yan JP; Ulloa A; Nyborg JK
Oncogene; 1999 Jun; 18(25):3766-72. PubMed ID: 10391685
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
30. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template.
Lu H; Pise-Masison CA; Fletcher TM; Schiltz RL; Nagaich AK; Radonovich M; Hager G; Cole PA; Brady JN
Mol Cell Biol; 2002 Jul; 22(13):4450-62. PubMed ID: 12052856
[TBL] [Abstract][Full Text] [Related]
32. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
Nicot C; Mahieux R; Opavsky R; Cereseto A; Wolff L; Brady JN; Franchini G
Oncogene; 2000 Apr; 19(17):2155-64. PubMed ID: 10815807
[TBL] [Abstract][Full Text] [Related]
33. Physical and functional interaction of SMADs and p300/CBP.
Pouponnot C; Jayaraman L; Massagué J
J Biol Chem; 1998 Sep; 273(36):22865-8. PubMed ID: 9722503
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell leukemia virus type I tax repression of p73beta is mediated through competition for the C/H1 domain of CBP.
Lemasson I; Nyborg JK
J Biol Chem; 2001 May; 276(19):15720-7. PubMed ID: 11279015
[TBL] [Abstract][Full Text] [Related]
35. Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein.
Kaida A; Ariumi Y; Ueda Y; Lin JY; Hijikata M; Ikawa S; Shimotohno K
Oncogene; 2000 Feb; 19(6):827-30. PubMed ID: 10698501
[TBL] [Abstract][Full Text] [Related]
36. Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.
Meertens L; Pise-Masison C; Quere N; Brady J; Gessain A; Mahieux R
Oncogene; 2004 Jul; 23(32):5447-58. PubMed ID: 15156194
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
38. Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent.
Georges SA; Giebler HA; Cole PA; Luger K; Laybourn PJ; Nyborg JK
Mol Cell Biol; 2003 May; 23(10):3392-404. PubMed ID: 12724399
[TBL] [Abstract][Full Text] [Related]
39. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
40. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
